Whenever the next raise comes. It will be to institutional investors. We won’t have to suffer the pain of SPP . And fingers crossed they are big US investors wanting us to migrate over to the Nasdaq. With stellar results from Azer-Cel, Vaxiniy and Oncarlytics in our back pocket. And a new FDA trial for Azer-Cel/Oncarlytics!
That’s where we want to be!
IMU Price at posting:
8.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)